デフォルト表紙
市場調査レポート
商品コード
1633706

モバイル心臓テレメトリの市場規模、シェア、成長分析:用途別、タイプ別、地域別 - 産業予測 2025~2032年

Mobile Cardiac Telemetry Market Size, Share, Growth Analysis, By Application (lead based, patch based), By Type (Hospitals, cardiac centres), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 256 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
モバイル心臓テレメトリの市場規模、シェア、成長分析:用途別、タイプ別、地域別 - 産業予測 2025~2032年
出版日: 2025年01月11日
発行: SkyQuest
ページ情報: 英文 256 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

モバイル心臓テレメトリの世界市場規模は、2023年に10億米ドルと評価され、2024年の10億1,000万米ドルから2032年には25億2,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは12.1%で成長する見通しです。

モバイル心臓テレメトリ(MCT)システムは、外来患者の心電図診断コストを削減し、リアルタイム分析を提供する、外来心臓モニタリングにおける重要な進歩です。このようなポータブル機器は、患者と医師の双方に利益をもたらし、ケアの効率を向上させる。心血管疾患(CVDs)の有病率の増加や老年人口の増加が、MCTシステムの市場成長に拍車をかけています。冠動脈性心疾患や脳血管疾患を含むCVDは、世界の死亡原因の上位を占めており、タバコの使用や食生活の乱れといった生活習慣の悪化がその要因となっています。MCTシステムは、ウェアラブルセンサーで構成され、患者を能動的にモニターし、即座に集中分析センターにデータを送信することで、ヘルスケア専門家にタイムリーな洞察を提供します。このような技術の統合は、診断と管理の改善を約束するものであり、MCTシステムは現代ヘルスケアに不可欠なツールと位置づけられています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

モバイル心臓テレメトリ市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 鉛ベース
  • パッチベース

モバイル心臓テレメトリ市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 心臓センター
  • その他

モバイル心臓テレメトリ市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Medtronic plc(Ireland)
  • Koninklijke Philips N.V.(Netherlands)
  • iRhythm Technologies, Inc.(USA)
  • Preventice Solutions(USA)
  • Boston Scientific Corporation(USA)
  • ScottCare Corporation(USA)
  • Applied Cardiac Systems, Inc.(USA)
  • Medicomp, Inc.(USA)
  • CardioNet, Inc.(USA)
  • LifeWatch AG(Switzerland)
  • Bittium Corporation(Finland)
  • GE Healthcare(USA)
  • Siemens Healthineers AG(Germany)
  • Hillrom Holdings, Inc.(USA)
  • Baxter International Inc.(USA)
  • AliveCor, Inc.(USA)
  • InfoBionic, Inc.(USA)

結論と推奨事項

目次
Product Code: SQMIG35A2202

Global Mobile Cardiac Telemetry Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.01 billion in 2024 to USD 2.52 billion by 2032, growing at a CAGR of 12.1% during the forecast period (2025-2032).

Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in ambulatory cardiac monitoring, offering real-time analysis and reducing electrocardiographic diagnosis costs for outpatients. These portable devices benefit both patients and physicians, enhancing care efficiency. The increasing prevalence of cardiovascular diseases (CVDs), alongside a growing geriatric population, is fueling market growth for MCT systems. CVDs, including coronary heart disease and cerebrovascular conditions, are the leading global cause of mortality, exacerbated by lifestyle factors like tobacco use and poor diet. MCT systems consist of wearable sensors that actively monitor patients and instantly transmit data to a centralized analysis center, providing timely insights for healthcare professionals. This integration of technology promises improved diagnosis and management, positioning MCT systems as essential tools in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mobile Cardiac Telemetry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mobile Cardiac Telemetry Market Segmental Analysis

Global Mobile Cardiac Telemetry Market is segmented by Application, Type and region. Based on Application, the market is segmented into lead based and patch based. Based on Type, the market is segmented into Hospitals, cardiac centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is significantly driven by advancements in healthcare technology that enhance patient monitoring capabilities. Growing awareness of innovative patch technology, alongside the launch of devices with improved functionalities, plays a crucial role in fueling this market's expansion. A key factor contributing to the rise of mobile cardiac telemetry (MCAT) systems is the alarming increase in mortality rates associated with cardiovascular diseases, exacerbated by widespread unhealthy lifestyle choices, including sedentary behavior, obesity, and tobacco use. Additionally, the heightened utilization of MCAT devices for the quick identification of arrhythmogenic risks, especially among COVID-19 patients in outpatient settings, further propels market growth.

Restraints in the Global Mobile Cardiac Telemetry Market

The global mobile cardiac telemetry market is likely to face significant restraints in the coming years, predominantly due to the high costs associated with advanced telemetry devices. This financial barrier may limit widespread adoption of mobile cardiovascular telemetry systems, ultimately hindering market growth during the forecast period. Additionally, stringent regulatory requirements and the potential for product recalls stemming from failures could further restrict revenue growth in this sector. As a result, these challenges may pose considerable obstacles for the mobile cardiac telemetry market, impacting its ability to expand effectively and reach its full potential in the healthcare industry.

Market Trends of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is witnessing substantial growth driven by advancements in technology that enhance patient monitoring capabilities. The increasing demand for non-invasive, remote healthcare solutions is propelling the adoption of mobile cardiac telemetry systems, enabling patients to maintain mobility while seamlessly transmitting real-time physiological data to healthcare providers. This innovation not only facilitates timely diagnosis and intervention but also aligns with the growing trend towards personalized medicine and chronic disease management. As healthcare systems embrace telehealth solutions, the market is poised for remarkable expansion, reflecting greater reliance on data-driven approaches to improve patient outcomes and operational efficiencies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Mobile Cardiac Telemetry Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • lead based
  • patch based

Global Mobile Cardiac Telemetry Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • cardiac centres
  • others

Global Mobile Cardiac Telemetry Market Size & CAGR (2025-2032)

  • North America (Application, Type)
    • US
    • Canada
  • Europe (Application, Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Preventice Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScottCare Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cardiac Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicomp, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioNet, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeWatch AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bittium Corporation (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hillrom Holdings, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AliveCor, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InfoBionic, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations